The Government of Kerala, in collaboration with Remidio, a leader in AI-driven ophthalmic screening solutions, has launched Nayanamritham 2.0, the world’s first government-led AI-assisted chronic eye disease screening program. This groundbreaking initiative integrates artificial intelligence (AI) into Kerala’s public health system, making it the first government-backed AI-powered eye screening initiative globally. The program aims to enhance early detection, streamline screening processes, and make eye care more accessible across the state.
About Nayanamritham 2.0
Following the success of Nayanamritham 1.0, which focused on diabetic retinopathy screening in Family Health Centers, Nayanamritham 2.0 takes a significant step forward by:
- Expanding Screening Scope: Now includes detection of three major chronic eye diseases:
- Diabetic Retinopathy (DR)
- Glaucoma
- Age-Related Macular Degeneration (AMD)
- AI-Powered Diagnosis:
- Optometrists are equipped with Remidio’s AI-enabled fundus cameras.
- The AI instantly classifies cases as referable or non-referable, ensuring quicker diagnosis and faster referrals.
- Wider Implementation:
- Screening now extended to Community Health Centers, Taluk Hospitals, and District Hospitals, ensuring comprehensive coverage at all healthcare levels.
- Enhancing Healthcare Efficiency:
- AI does not replace healthcare professionals but empowers them.
- Optometrists handle routine cases, while ophthalmologists focus on advanced cases, ensuring high-quality patient care.
Significance of Nayanamritham 2.0
- First AI-driven public health eye screening program globally, setting a global precedent in ophthalmic AI integration.
- Faster, more efficient, and cost-effective screening, ensuring early detection and timely intervention.
- Reduces preventable blindness by improving accessibility to quality eye care.
- Strengthens Kerala’s healthcare system, positioning the state as a leader in AI-driven medical advancements.
About Remidio
Remidio, an Indian health-tech company, specializes in AI-driven eye care solutions. The company collaborates with Kerala’s health department to:
- Improve early detection rates for chronic eye diseases.
- Reduce preventable blindness through AI-powered diagnostics.
- Enhance patient outcomes by integrating scalable, data-driven approaches into public healthcare.
By integrating Remidio’s AI-powered 3-in-1 ophthalmic technology, Kerala is showcasing the transformative potential of AI in public health, setting a new benchmark for government and health-tech collaboration.